Retrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-institution Real Life Clinical Data
2021 · Clinical Colorectal Cancer · 22 citations
https://doi.org/10.1016/j.clcc.2021.06.002